机构:[1]Peking Union Med Coll Hosp, Beijing, Peoples R China[2]Geneplus Beijing Inst, Beijing, Peoples R China[3]Hunan Canc Hosp, Changsha, Hunan, Peoples R China[4]Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China[5]Sichuan Canc Hosp, Chengdu, Peoples R China四川省肿瘤医院[6]Geneplus Beijing, Beijing, Peoples R China
第一作者机构:[1]Peking Union Med Coll Hosp, Beijing, Peoples R China[2]Geneplus Beijing Inst, Beijing, Peoples R China[3]Hunan Canc Hosp, Changsha, Hunan, Peoples R China[4]Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China[5]Sichuan Canc Hosp, Chengdu, Peoples R China[6]Geneplus Beijing, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Xiang Yang,Zhu Shan,Cao Dongyan,et al.Integrating the genomic and TCR repertoire signatures predicts prognosis in primary epithelial ovarian cancer.[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e17547.
APA:
Xiang, Yang,Zhu, Shan,Cao, Dongyan,Wan, Xi-Run,Zhang, Chunliu...&Xia, Xuefeng.(2021).Integrating the genomic and TCR repertoire signatures predicts prognosis in primary epithelial ovarian cancer..JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA:
Xiang, Yang,et al."Integrating the genomic and TCR repertoire signatures predicts prognosis in primary epithelial ovarian cancer.".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)